<DOC>
	<DOCNO>NCT00140491</DOCNO>
	<brief_summary>The goal pilot study evaluate effect Vision Restoration Therapy , VRT , visual function patient unilateral bilateral AION , good central vision ( least 20/60 ) altitudinal visual field defect .</brief_summary>
	<brief_title>Vision Restoration Therapy ( VRT ) Treat Non-Arteritic Anterior Ischemic Optic Neuropathy</brief_title>
	<detailed_description>Anterior ischemic optic neuropathy ( AION ) one common cause optic neuropathy age 50 . There currently available treatment although 40 % patient spontaneous improvement within first month , patient remain visually devastate . About 50 % patient retain relatively spared central visual acuity inferior altitudinal visual field defect . These patient usually complain difficulty reading loss depth perception . Recently , training-induced enlargement visual field defect demonstrate patient VF defect secondary lesion retrochiasmal visual pathway . This computer-based Vision Restoration Therapy ( VRT ) develop Germany FDA-cleared United States past one year . VRT currently available Emory patient homonymous hemianopia . Patients work personally-designed software ( laptop home ) twice daily ( 30 minute ) 6 month . Zones partially damage neuron , usually locate intact damage area visual field ( transition zone ) deliberately stimulate VRT . There anecdotal evidence visual restoration therapy may helpful enlarge visual field patient optic neuropathy . The goal pilot study evaluate effect VRT visual function patient unilateral bilateral AION , good central vision ( least 20/60 ) altitudinal visual field defect . The effect VRT evaluate visual acuity , color vision , stereo vision , Humphrey VF ( 24-2 SITA standard ) testing , scale evaluate read speed vision-based quality life . These measure repeat VRT , 3 month , 6 month , 1 year VRT . 20 patient include study . Patients randomized inclusion VRT sham ( placebo ) -training ( 10 group ) . The 10 patient receive sham train receive VRT follow 6 month choose . All data analyze blinded fashion . The company develop VRT United States ( NOVAVISION ) agree provide VRT sham-training .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Optic Neuropathy , Ischemic</mesh_term>
	<criteria>Patients see Dr Biousse Dr Newman NeuroOphthalmology Unit Emory University . Age ≥ 30 year . Diagnosis nonarteritic ischemic optic neuropathy least 6 month prior inclusion . Uni bilateral AION ( case bilateral AION , one eye include study ) . Best correct visual acuity least 20/60 study eye Altitudinal arcuate visual field defect , split fixation &gt; 10 decibel difference horizontal meridian . Stable visual function demonstrate two stable visual acuity measurement two automate visual field testing prior inclusion study . Patient willing , able , spend 60 minutesaday 6 month work computer . Patient cognitively physically unable perform reliable automate perimetry test ( 242 SITA Standard program ) ( grossly equivalent effort attention need perform VRT daily home ) . Other cause optic neuropathy . Associated ocular disease require treatment responsible visual loss ( untreated significant cataract , glaucoma , age relate macular degeneration , etc… ) . Visual acuity bad 20/60 study eye . Nonstable visual field defect previous evaluation . Epilepsy .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Non-Arteritic Anterior Ischemic Optic Neuropathy</keyword>
	<keyword>Visual Field Defect</keyword>
	<keyword>Neuroplasticity</keyword>
	<keyword>Rehabilitation</keyword>
</DOC>